Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0941820150250020120
Korean Journal of Clinical Pharmacy
2015 Volume.25 No. 2 p.120 ~ p.129
Pharmacodynamic Drug-Drug Interactions Considered to be Added in the List of Contraindications with Pharmacological Classification in Korea
Je Nam-Kyung

Kim Dong-Sook
Kim Ju-Yun
Lee Suk-Hyang
Abstract
Objectives: Drug utilization review program in Korea has provided ¡®drug combinations to avoid (DCA)¡¯ alerts to physicians and pharmacists to prevent potential adverse drug events or inappropriate drug use. Seven hundred and six DCA pairs have been announced officially by the Ministry of Food and Drug Safety (MFDS) by March, 2015. Some DCA pairs could be grouped based on the drug interaction mechanism and its consequences. This study aimed to investigate the drug-drug interaction (DDI) pairs, which may be potential DCAs, generated by the drug class-drug class interaction method.
Methods: Eleven additive/synergistic and one antagonistic drug class-drug class interaction groups were identified. By combining drugs of two interacting drug class groups, numerous DDI pairs were made. The status and severity of DDI pairs were examined using Lexicomp and Micromedex. Also, the DCA listing rate was calculated.

Results: Among 258 DDI pairs generated by the drug class-drug class interaction method, only 142 pairs were identified as official DCA pairs by the MFDS. One hundred and four pairs were identified as potential DCA pairs to be listed. QT prolonging agents-QT prolonging agents, triptans-ergot alkaloids, tricyclic antidepressants-monoamine oxidase inhibitors, and dopamine agonists-dopamine antagonists were identified as drug class-drug class interaction groups which have less than 50 % DCA listing rate.

Conclusion: To improve the clinicians¡¯ adaptability to DCA alerts, the list of DCA pairs needs to be continuously updated.
KEYWORD
drug combinations to avoid, drug-drug interactions, pharmacodynamics, pharmacokinetics
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)